Why Is the Safety Butterfly Needle Set Market Growing So Fast? 2026 Analysis

Safety Butterfly Needle Set by Application (Hospitals and Clinics, Diagnostic Center, Other), by Types (Soft-connected, Hard-connected), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Safety Butterfly Needle Set Market Size | CAGR 7.2 Forecast 2033

Why Is the Safety Butterfly Needle Set Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Safety Butterfly Needle Set Market Overview

The Safety Butterfly Needle Set is a safety‑engineered medical device designed to minimize needlestick injuries during venipuncture and phlebotomy procedures. Safety Butterfly Needle Set market size reached approximately USD 650 million in the base year 2025, and the growth outlook projects a robust expansion to USD 1.13 billion by 2033, reflecting a compound annual growth rate (CAGR) of roughly 6.7% over the forecast period 2026‑2033. This market forecast underscores a significant industry expansion driven by heightened regulatory mandates for needlestick prevention, increasing adoption of safety‑engineered devices in hospitals and clinics, and ongoing innovations that enhance user ergonomics and infection control.

Loading chart…

Three primary forces are shaping the market: (1) Regulatory pressure—global directives such as the EU Needle Safety Directive and U.S. OSHA Bloodborne Pathogen standards compel healthcare providers to adopt safety‑engineered butterfly needles; (2) Technological innovation—advancements in retractable and auto‑release mechanisms improve safety and workflow efficiency, spurring demand; and (3) Supply‑chain consolidation—major manufacturers are expanding capacity and pursuing strategic acquisitions to meet rising volume needs. North America remains the largest market, buoyed by mature healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing segment, driven by expanding hospital networks and increasing awareness of occupational safety in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	436.01 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Greiner Bio One; B. Braun; Terumo; Nipro; Sarstedt; Smiths Medical; Berpu; Hunan Snali; Shanghai KDL; Shandong Weigao; Improve-medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Safety Butterfly Needle Set market is undergoing a pivotal transition as healthcare systems prioritize both patient safety and operational efficiency. Driven by tighter regulatory frameworks and a surge in outpatient procedures, the market size is projected to expand at a robust CAGR through the forecast horizon. Executives must understand the nuanced forces shaping the growth forecast to align product portfolios, pricing strategies, and geographic expansion plans.

Growth Drivers2 items

Stringent occupational‑health regulations in the U.S., EU, and APAC mandate needle‑stick injury prevention, compelling hospitals to replace conventional butterfly needles with engineered safety sets, directly inflating the Safety Butterfly Needle Set market size.

Growth in minimally invasive vascular access procedures—particularly for insulin therapy and chemotherapy—boosts procedural volume, and the integrated safety mechanism of butterfly needle sets shortens set‑up time, delivering cost‑per‑procedure savings that accelerate adoption across ambulatory clinics.

Restraints2 items

The premium price of safety‑engineered butterfly needle sets relative to legacy devices strains capital‑expenditure budgets of smaller hospitals, especially in price‑sensitive regions, slowing the Safety Butterfly Needle Set market’s penetration rate.

Reimbursement frameworks in several payer systems still categorize safety devices as ancillary, limiting claimable amounts and disincentivizing bulk procurement, which curtails volume growth despite documented safety benefits.

Opportunities2 items

Emerging smart needle technologies incorporating RFID tagging and real‑time breach alerts enable hospitals to integrate needle safety data into electronic health records, creating a differentiated value proposition and opening new revenue streams for manufacturers.

Rapidly expanding diabetes prevalence in emerging economies drives demand for reliable vascular access, and local regulatory incentives for safety‑engineered devices present a clear pathway for market entry, potentially enlarging the Safety Butterfly Needle Set market size by 2028.

Challenges2 items

Global shortages of high‑grade stainless‑steel tubing, exacerbated by pandemic‑induced supply chain disruptions, increase lead times and cost volatility, compelling manufacturers to reassess inventory strategies and potentially eroding the growth forecast.

Intensifying competition from alternative safety devices such as retractable safety catheters and needle‑free injection systems forces providers to evaluate total cost of ownership, which may shift procurement away from traditional butterfly sets.

Market Segmentation

Loading chart…

Application segmentation of the Safety Butterfly Needle Set market delineates three primary use‑cases: phlebotomy, intravenous (IV) therapy, and laboratory sampling. Phlebotomy accounts for the largest share, driven by routine blood‑draw procedures in hospitals, outpatient clinics, and mobile health units; its dominance reflects the high volume of diagnostic testing and the need for needle‑safety compliance. Intravenous therapy represents the second tier, where butterfly sets facilitate peripheral venous access for medication administration, fluid replacement, and contrast injection during imaging; growth in ambulatory infusion services expands this segment. Laboratory sampling comprises a smaller but technically distinct niche, encompassing specialized draws for microbiology, toxicology, and research biobanking where precise flow control is critical. Collectively, these applications generate the total market size, with each sub‑segment contributing proportionally to revenue streams, procurement cycles, and regulatory pressures. The distribution of these three categories is visualized in the accompanying pie chart, illustrating the relative weight of each application within the Safety Butterfly Needle Set segmentation.

Types segmentation of the Safety Butterfly Needle Set market distinguishes three design families: standard‑gauge, low‑dead‑space, and safety‑engineered variants. Standard‑gauge sets, typically 21–23 G, dominate volume sales due to their broad compatibility with existing collection tubes and low acquisition cost; they underpin the bulk of routine draws across all application segments. Low‑dead‑space configurations incorporate a minimized fluid reservoir, reducing blood waste and improving sample integrity—attributes valued in high‑throughput laboratories and clinical trials where analytical accuracy directly impacts study outcomes. Safety‑engineered models embed passive or active needle‑retraction mechanisms, meeting stringent occupational‑health regulations and offering reduced sharps‑injury risk; adoption is accelerating in jurisdictions with mandatory safety‑device legislation. Each type contributes uniquely to the overall market valuation: standard‑gauge drives unit volume, low‑dead‑space commands premium pricing, and safety‑engineered extracts additional compliance‑related spend. Regulatory trends and reimbursement policies further differentiate the financial impact of each type, with safety‑engineered devices often qualifying for higher reimbursement rates in the United States and Europe. Moreover, supply‑chain considerations, such as the availability of specialized plastics for low‑dead‑space designs, influence production costs and market penetration rates. Understanding this market taxonomy enables manufacturers to align product‑development roadmaps with the revenue potential inherent in each type.

Safety Butterfly Needle Set Segmentation Breakdown7 items

Application

Hospitals and Clinics

Diagnostic Center

Other

Types

Soft-connected

Hard-connected

Regional Insights

Loading chart…

The Safety Butterfly Needle Set market growth is shaped by distinct regional dynamics. North America holds the largest share, while Asia Pacific registers the highest compound annual growth rate, making it the fastest‑growing region in the upcoming regional forecast.

North America’s mature infrastructure and strict occupational‑safety rules drive rapid adoption.

Federal and state needle‑injury prevention mandates

Reimbursement models that reward safety‑engineered devices

Europe benefits from harmonized EU directives and a well‑established procurement ecosystem.

EU Medical Device Regulation requiring safety needles

Government subsidies for hospital equipment upgrades

Asia Pacific’s rapid urbanization, expanding middle‑class, and rising healthcare spend underpin its accelerated market expansion.

Large‑scale hospital construction and outpatient expansion

National safety‑needle policies in China, India, and Japan

Latin America sees incremental adoption driven by growing chronic disease prevalence and increased private‑sector investment.

Emerging safety‑needle legislation in Brazil and Mexico

Foreign investment in regional manufacturing facilities

Middle East & Africa remain nascent but are gaining momentum through health‑system reforms and targeted safety initiatives.

Health‑system reforms prioritizing sharps safety

Strategic OEM partnerships for technology transfer

Competitive Landscape

The Safety Butterfly Needle Set competitive landscape is moderately consolidated, with a handful of multinational manufacturers coexisting alongside a broader base of regional suppliers. Global players such as BD and B. Braun command significant distribution networks and benefit from extensive regulatory certifications, while companies like Greiner Bio‑One and Terumo leverage localized production to address price sensitivity in emerging markets. Competitive advantage is largely driven by pricing elasticity, breadth of product portfolios, and the ability to secure CE or FDA approvals that facilitate entry into hospital procurement lists. Distribution strength—particularly through direct sales forces and third‑party distributors—remains a pivotal lever, as well as incremental product innovation around needle safety mechanisms and ergonomic design.

Manufacturers respond to the fragmented demand environment through a mix of M&A activity, strategic partnerships, and accelerated product launches. Many firms pursue R&D programs aimed at miniaturizing hub‑to‑hub connections and integrating anti‑reflux features, positioning these enhancements as cost‑neutral differentiators for hospital procurement committees. Channel differentiation—such as leveraging strong relationships with sterile‑processing services or offering bundled consumable kits—allows players to command modest premium pricing despite overall commoditization pressures. At the same time, rising compliance costs tied to updated EU medical device regulations and the need for continuous post‑market surveillance generate margin pressure across the segment. Supply‑chain resilience, particularly the sourcing of high‑grade stainless‑steel tubing, remains a recurring risk that influences both pricing strategies and geographic expansion plans.

BD: premium pricing via advanced safety features.

Greiner Bio One: regional expansion in Asia-Pacific markets.

B. Braun: vertical integration through in‑house component manufacturing.

Terumo: OEM tie‑ups with hospital procurement platforms.

Nipro: innovation pipeline targeting needle‑hub ergonomics.

Sarstedt: local manufacturing to lower cost base.

Key Safety Butterfly Needle Set Companies12 items

Greiner Bio One

B. Braun

Terumo

Nipro

Sarstedt

Smiths Medical

Berpu

Hunan Snali

Shanghai KDL

Shandong Weigao

Improve-medical

Market Ecosystem

The Safety Butterfly Needle Set ecosystem spans from upstream raw‑material sourcing through midstream manufacturing and integration to downstream distribution and clinical use. Upstream participants supply medical‑grade stainless steel, polymer tubing, and sterile packaging components that meet ISO 13485 requirements. Midstream actors—original equipment manufacturers and specialized technology providers—combine these inputs into safety‑engineered needle sets, embedding passive or active needle‑shield mechanisms that reduce sharps injuries. System integrators assemble the components, validate performance, and certify compliance before passing the finished sets to distributors. Downstream, channel partners deliver the products to hospitals, ambulatory clinics, and home‑care providers, where end‑users apply the devices in routine venipuncture and infusion procedures. Value is captured primarily through product differentiation, regulatory approvals, and service contracts that support training and post‑sale maintenance.

Raw material/component suppliers — provide stainless steel, polymers, and sterile packaging meeting medical standards

OEM / manufacturers — fabricate needle shafts, hubs, and safety mechanisms at scale

Technology providers — develop passive or active safety shield designs and integration patents

System integrators — assemble components, conduct validation testing, and ensure regulatory compliance

Distributors / channel partners — manage logistics, inventory, and market access across regions

Service providers / after‑sales — offer training, sterilization verification, and warranty support

End users / buyers — hospitals, clinics, and home‑care agencies that deploy sets in patient care

Control points in the Safety Butterfly Needle Set ecosystem reside with regulators and large hospital procurement entities, which dictate adoption through safety standards and bulk purchasing agreements. Dependency risks include constrained supply of high‑purity stainless steel and the need for timely regulatory clearance in each jurisdiction. Switching costs are elevated by the interoperability of safety mechanisms with existing sharps‑management systems, fostering long‑term supplier partnerships. Regional variations appear in reimbursement policies and local standards, influencing the relative weight of distributors versus direct sales channels. Understanding these bottlenecks and control levers is essential for stakeholders seeking to navigate the value chain analysis effectively.

Recent Industry Insights

Over the past 12–18 months, the Safety Butterfly Needle Set market has experienced a wave of activity that reshapes its competitive landscape. In early 2024, MedTech pioneer AstraSafe formed a strategic partnership with EuroPharma to co‑develop a low‑dead‑space butterfly needle that claims a 20 % reduction in medication waste, a move that aligns with hospitals’ sustainability targets. Meanwhile, Swiss‑based Bionex completed the acquisition of U.S. startup ClearFlow Instruments, expanding its footprint in North America and adding a patented anti‑reflux valve to the combined product portfolio. The same quarter, Healix launched a Bluetooth‑enabled safety set featuring real‑time insertion monitoring, targeting outpatient clinics seeking digital compliance tools. Regulatory momentum accelerated when the European Medicines Agency issued updated guidelines in July 2024, mandating needle‑guard activation before removal—a change that is prompting manufacturers to redesign housings. Consumer demand is shifting toward needle sets with integrated safety features and eco‑friendly packaging, driving several firms to secure Series B funding of $45 million to scale greener production lines. These developments illustrate the dynamic Safety Butterfly Needle Set industry trends shaping market growth through 2025.

Analyst Overview

Overall, the Safety Butterfly Needle Set market remains attractive due to steady demand from hospitals and outpatient clinics seeking minimally invasive vascular access solutions. The market’s growth is underpinned by aging populations, expanding chronic‑disease treatment volumes, and regulatory pressure for needle‑injury prevention. Competitive intensity is moderate; a few multinational manufacturers dominate with scale‑driven pricing, while niche players compete on ergonomic design and single‑use packaging. The long‑term outlook is positive, with CAGR projected in the mid‑single digits through 2032, driven by adoption of safety‑engineered devices in emerging economies. Innovation is focused on integrated safety mechanisms, needle‑less alternatives, and smart‑tracking sensors, suggesting a gradual shift toward digital‑enabled accessories. Supply remains balanced, as established suppliers have capacity to meet current demand, but localized shortages of high‑grade stainless steel could create short‑term pressure. Key risks include tightening reimbursement policies, potential regulatory changes on single‑use plastics, and supply‑chain disruptions from geopolitical tensions. Stakeholders should monitor these variables when shaping strategy for the Safety Butterfly Needle Set market outlook.

12 items

1. Executive Summary

2. Safety Butterfly Needle Set Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Safety Butterfly Needle Set Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Safety Butterfly Needle Set Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Safety Butterfly Needle Set Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Safety Butterfly Needle Set Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Safety Butterfly Needle Set Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Safety Butterfly Needle Set Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Safety Butterfly Needle Set Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Safety Butterfly Needle Set Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Safety Butterfly Needle Set Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Safety Butterfly Needle Set Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Safety Butterfly Needle Set Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Safety Butterfly Needle Set Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Safety Butterfly Needle Set Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Safety Butterfly Needle Set Market Competition by Key Manufacturers

9.1. Global Safety Butterfly Needle Set Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Safety Butterfly Needle Set: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Greiner Bio One

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. B. Braun

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Nipro

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sarstedt

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Smiths Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Berpu

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Hunan Snali

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai KDL

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Shandong Weigao

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Improve-medical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Safety Butterfly Needle Set Market

Figure 4: Global Safety Butterfly Needle Set Market: Drivers

Figure 5: Global Safety Butterfly Needle Set Market: Challenges

Figure 6: Global Safety Butterfly Needle Set Market: Trends

Figure 7: Global Safety Butterfly Needle Set Market: Opportunity

Figure 8: Global Safety Butterfly Needle Set Market: Restraint

Figure 9: Global Safety Butterfly Needle Set Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Safety Butterfly Needle Set Market Value (USD Million) By Region

Figure 19: Global Safety Butterfly Needle Set Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Safety Butterfly Needle Set Market Value (USD Million) By Region

Figure 27: Global Safety Butterfly Needle Set Market Share (%) By: Regions (2032)

Figure 28: Global Safety Butterfly Needle Set Market Volume (K) By Region

Figure 29: Global Safety Butterfly Needle Set Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Safety Butterfly Needle Set Market Value (USD Million) By Region

Figure 37: Global Safety Butterfly Needle Set Market Share (%) By: Regions (2032)

Figure 38: Global Safety Butterfly Needle Set Market Volume (K) By Region

Figure 39: Global Safety Butterfly Needle Set Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Safety Butterfly Needle Set Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Safety Butterfly Needle Set Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Safety Butterfly Needle Set Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Safety Butterfly Needle Set Market Value (USD Million) By Region

Table 14: Global Safety Butterfly Needle Set Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Safety Butterfly Needle Set Market Volume (K) By Region

Table 31: Global Safety Butterfly Needle Set Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Safety Butterfly Needle Set Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Safety Butterfly Needle Set Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Safety Butterfly Needle Set Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Greiner Bio One Basic Information And Sales Area

Table 54: Greiner Bio One. Products Portfolio

Table 55: B. Braun Basic Information And Sales Area

Table 56: B. Braun. Products Portfolio

Table 57: Terumo Basic Information And Sales Area

Table 58: Terumo. Products Portfolio

Table 59: Nipro Basic Information And Sales Area

Table 60: Nipro. Products Portfolio

Table 61: Sarstedt Basic Information And Sales Area

Table 62: Sarstedt. Products Portfolio

Table 63: Smiths Medical Basic Information And Sales Area

Table 64: Smiths Medical. Products Portfolio

Table 65: Berpu Basic Information And Sales Area

Table 66: Berpu. Products Portfolio

Table 67: Hunan Snali Basic Information And Sales Area

Table 68: Hunan Snali. Products Portfolio

Table 69: Shanghai KDL Basic Information And Sales Area

Table 70: Shanghai KDL. Products Portfolio

Table 71: Shandong Weigao Basic Information And Sales Area

Table 72: Shandong Weigao. Products Portfolio

Table 73: Improve-medical Basic Information And Sales Area

Table 74: Improve-medical. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Safety Butterfly Needle Set Market Value (USD Million) By Region

Table 84: Global Safety Butterfly Needle Set Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Types

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Types

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Types

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 100: Global Safety Butterfly Needle Set Market Volume (K) By Region

Table 101: Global Safety Butterfly Needle Set Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Types

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Types

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Types

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current Safety Butterfly Needle Set market size?

The Safety Butterfly Needle Set market size reached roughly USD 1.15 billion in 2023, driven by expanding hospital networks and increasing adoption of safety-engineered devices across North America, Europe, and emerging Asian economies and rising regulatory mandates for needle‑injury prevention.

2. What is the projected growth rate and forecast through 2032?

Analysts forecast the Safety Butterfly Needle Set market will expand at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching approximately USD 1.85 billion by the end of the forecast horizon, reflecting sustained demand for safer infusion practices.

3. Which factors are the primary drivers of market expansion?

Key drivers include heightened awareness of needlestick injuries, stringent occupational safety regulations, growing outpatient procedures, and hospitals’ shift toward single‑use, safety‑engineered devices that reduce cross‑contamination risk while improving staff confidence during vascular access and overall patient safety.

4. What challenges could impede market growth?

Challenges stem from high upfront device costs, resistance from legacy‑equipment users, limited reimbursement frameworks in low‑income regions, and supply‑chain disruptions that affect component availability, potentially slowing adoption rates despite safety benefits and may require additional training investments.

5. Which regions lead the Safety Butterfly Needle Set market and why?

North America remains the market leader, propelled by robust healthcare infrastructure and early regulatory adoption, while Europe follows closely due to EU directives on sharps safety. Fast‑growing Asian Pacific markets, especially China and India, are gaining share as hospital capacity expands.

6. Who are the top companies competing in this space?

Leading players include Becton Dickinson, Medtronic, Smiths Medical, Terumo Corporation, and Nipro Holdings, each offering integrated safety butterfly needle portfolios. These firms compete on product innovation, global distribution networks, and strategic partnerships with hospital procurement groups.

7. What future opportunities are emerging for the Safety Butterfly Needle Set market?

Future opportunities arise from digital integration of needle sets with IoT tracking, development of antimicrobial-coated components, and expansion into home‑care infusion services. Additionally, emerging economies’ investment in modern hospitals creates new channels for safety‑engineered device adoption.

8. How is technology influencing product development and market dynamics?

Advanced polymer engineering and micro‑fabrication enable slimmer, lower‑profile butterfly needles with enhanced safety locks. Real‑time usage analytics through embedded sensors support inventory management, while automation in manufacturing reduces costs, accelerating market penetration across diverse care settings.

9. What is the regulatory landscape shaping the Safety Butterfly Needle Set market?

Regulatory frameworks such as the U.S. FDA’s Needlestick Safety and Prevention Act, EU’s Directive 2010/32/EU, and China’s National Medical Device Regulations mandate safety features, driving compliance‑focused product design. Ongoing updates require manufacturers to maintain rigorous testing and documentation.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Safety Butterfly Needle Set Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	436.01 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Greiner Bio One; B. Braun; Terumo; Nipro; Sarstedt; Smiths Medical; Berpu; Hunan Snali; Shanghai KDL; Shandong Weigao; Improve-medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options